← All diseases Lungs and airways

Pulmonary fibrosis (IPF)

Automatically tracked from PubMed and ClinicalTrials.gov, newest on top. Nothing ever disappears here: what you keep in your favorites remains findable. · RSS feed of this disease · only the strongest evidence

Search Period All yearsLast 12 monthsLast 5 years Topic All topicsGeneralNutrition and dietAlternative treatment methods Type of research Any type of researchHighest evidence only (50)Meta-analysis (17)Treatment guideline (1)Systematic review (13)Randomized trial (11)Phase 3 study (8)Clinical trial (616)Review article (254)Early study (phase 1 or 2) (26)Laboratory or animal study (64)Case report (61)Commentary or editorial (47)Retracted publication (1) Studies currently recruiting participants only (33)

Filter

Publications and studies (1954)

• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Assessment of Lung Movement With Computed Tomography (CT) (2020-05-01) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. A Pilot Study of Aerosol Interferon-gamma for Treatment of Idiopathic Pulmonary Fibrosis (2020-04-28) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Effects of Oxymizer Pendant Cannula Versus Conventional Nasal Cannula During Endurance Shuttle Walk Tests in Hypoxemic Patients With Idiopathic Pulmonary Fibrosis (2020-04-16) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Evaluation of Novel Lung Function Parameters in Patients With Interstitial Lung Disease (ILD) (2020-03-24) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. STX-100 in Patients With Idiopathic Pulmonary Fibrosis (IPF) (2020-02-28) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Supplemental Oxygen in Pulmonary Fibrosis (2020-02-25) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Home Monitoring in Idiopathic Pulmonary Fibrosis; Improving Use of Anti-fibrotic Medication and Quality of Life (2020-01-30) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Palliative Care and Quality of Life in Idiopathic Pulmonary Fibrosis (2020-01-29) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Pirfenidone as Bridging Therapy for Lung Transplant in Patients Suffering From Idiopathic Pulmonary Fibrosis (2020-01-27) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Digital Auscultation Test - IPF Data Collection (2020-01-27) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of BBT-877 in Healthy Subjects (2020-01-18) ♡
• Epithelial cell senescence induces pulmonary fibrosis through Nanog-mediated fibroblast activation. (2019/12/31) ♡
• The overexpression of peroxiredoxin-4 affects the progression of idiopathic pulmonary fibrosis. (2019/12/30) ♡
• Particulate Matter Increases the Severity of Bleomycin-Induced Pulmonary Fibrosis through KC-Mediated Neutrophil Chemotaxis. (2019/12/28) ♡
• K(Ca)3.1 channel blockade attenuates microvascular remodelling in a large animal model of bleomycin-induced pulmonary fibrosis. (2019/12/27) ♡
• Change of surfactant protein D and A after renal ischemia reperfusion injury. (2019/12/26) ♡
• Laboratory or animal researchiNo research in humans yet. Promising in a test tube or in mice unfortunately means nothing for patients. Targeting MAP3K19 prevents human lung myofibroblast activation both in vitro and in a humanized SCID model of idiopathic pulmonary fibrosis. (2019/12/24) ♡
• Caveolin-1 gene therapy inhibits inflammasome activation to protect from bleomycin-induced pulmonary fibrosis. (2019/12/23) ♡
• Left Atrial Volume as a Biomarker of Atrial Fibrillation at Routine Chest CT: Deep Learning Approach. (2019/12/19) ♡
• Validation of the King's Brief Interstitial Lung Disease questionnaire in Idiopathic Pulmonary Fibrosis. (2019/12/19) ♡
• Prognostic differences among patients with idiopathic interstitial pneumonias with acute exacerbation of varying pathogenesis: a retrospective study. (2019/12/18) ♡
• Idiopathic pulmonary fibrosis and occupational risk factors. (2019/12/17) ♡
• Hexokinase 2 couples glycolysis with the profibrotic actions of TGF-β. (2019/12/17) ♡
• Forced Vital Capacity (FVC) decline, mortality and healthcare resource utilization in idiopathic pulmonary fibrosis. (2019/12/17) ♡
• Clinical significance of self-reported cough intensity and frequency in patients with interstitial lung disease: a cross-sectional study. (2019/12/16) ♡
• miR-200 family members reduce senescence and restore idiopathic pulmonary fibrosis type II alveolar epithelial cell transdifferentiation. (2019/12/16) ♡
• Exosomal miRNA Let-7 from Menstrual Blood-Derived Endometrial Stem Cells Alleviates Pulmonary Fibrosis through Regulating Mitochondrial DNA Damage. (2019/12/16) ♡
• Glycogen Synthase Kinase-3β Inhibition with 9-ING-41 Attenuates the Progression of Pulmonary Fibrosis. (2019/12/12) ♡
• Caveolin-1-derived peptide limits development of pulmonary fibrosis. (2019/12/11) ♡
• IPF patients are limited by mechanical and not pulmonary-vascular factors - results of a derivation-validation cohort study. (2019/12/11) ♡
• Targeted regulation of fibroblast state by CRISPR-mediated CEBPA expression. (2019/12/11) ♡
• Meta-analysisiAll studies on one question combined and calculated together. This is the strongest form of research that exists: a single loose study can be coincidence, dozens together much less so. The label says something about the design, not about the outcome — which can also be that something does NOT work. Systematic review and meta-analysis of the prognosis and prognostic factors of interstitial pneumonia with autoimmune features. (2019/12/11) ♡
• Aerosol Pirfenidone Pharmacokinetics after Inhaled Delivery in Sheep: a Viable Approach to Treating Idiopathic Pulmonary Fibrosis. (2019/12/10) ♡
• Primary immunodeficiency-related bronchiectasis in adults: comparison with bronchiectasis of other etiologies in a French reference center. (2019/12/04) ♡
• Concordance between sequential transbronchial lung cryobiopsy and surgical lung biopsy in patients with diffuse interstitial lung disease. (2019/12/04) ♡
• Correction: Quantitative CT analysis of honeycombing area predicts mortality in idiopathic pulmonary fibrosis with definite usual interstitial pneumonia pattern: A retrospective cohort study. (2019/12/02) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Clinical course and management of idiopathic pulmonary fibrosis. (2019/12/02) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. The Future of Pharmacological Treatment in Idiopathic Pulmonary Fibrosis. (2019/12/01) ♡
• Palmitic Acid-Rich High-Fat Diet Exacerbates Experimental Pulmonary Fibrosis by Modulating Endoplasmic Reticulum Stress. (2019/12/01) ♡
• The effect of emphysema on survival in patients with idiopathic pulmonary fibrosis: A retrospective study in Taiwan. (2019/12/01) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. A case report of acute fibrinous and organizing pneumonia. (2019/12/01) ♡
• Breathe, breathe in the air: the anti-CCN2 antibody pamrevlumab (FG-3019) completes a successful phase II clinical trial for idiopathic pulmonary fibrosis. (2019/12/01) ♡
• [Surgical treatment of lung cancer patients with idiopathic pulmonary fibrosis]. (2019/12/01) ♡
• FoxD1-driven CCN2 deletion causes axial skeletal deformities, pulmonary hypoplasia, and neonatal asphyctic death. (2019/12/01) ♡
• A Phase 1b Study of Vismodegib with Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis. (2019/12/01) ♡
• Predictive factors of mortality in rheumatoid arthritis-associated interstitial lung disease analysed by modified HRCT classification of idiopathic pulmonary fibrosis according to the 2018 ATS/ERS/JRS/ALAT criteria. (2019/12/01) ♡
• A cross-sectional evaluation of the idiopathic pulmonary fibrosis patient satisfaction and quality of life with a care coordinator. (2019/12/01) ♡
• Joint Models for Time-to-Event Data and Longitudinal Biomarkers of High Dimension. (2019/12/01) ♡
• Acute exacerbation of idiopathic pulmonary fibrosis: who to treat, how to treat. (2019/12/01) ♡
• Comparison of disease progression subgroups in idiopathic pulmonary fibrosis. (2019/11/29) ♡

↑ Back to top

codex.care does not provide medical advice. Always discuss symptoms, medication, and treatment choices with your own healthcare provider.